In an effort to expand access to affordable, quality maternal health (MH) medicines,
Jhpiego has built business cases for investing in high-quality MH drugs in low-resource
settings. These business cases collectively map manufacturers of MH medicines,
approximate market sizes for the medicines, and characterize market dynamics.
Ultimately, we hope to promote investment in the production and supply of high-quality
MH products that will be affordable for African and southeast Asian markets. Support for
this project was provided by PATH on behalf of the Reproductive Health Supplies
This effort has generated three written case studies: on oxytocin, misoprostol, and
magnesium sulfate (MgSO4). In addition, an “Accelovate Maternal Health Drug
Business Assessments” Excel file contains global market data pertaining to these three
products. The Excel file will allow users to examine our data and to manipulate
assumptions to generate tailored market projections. The Excel file can be found here.